NEPHROS INC - Common Stock - $0.001 par value (NEPH)

CUSIP: 640671400

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock - $0.001 par value
Shares outstanding
10,630,964
Total 13F shares
4,502,818
Share change
+129,327
Total reported value
$37,780,000
Price per share
$8.39
Number of holders
17
Value change
+$1,367,226
Number of buys
6
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 640671400?
CUSIP 640671400 identifies NEPH - NEPHROS INC - Common Stock - $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NEPH - NEPHROS INC - Common Stock - $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WEXFORD CAPITAL LP
13F
Company
32%
3,395,579
$21,391,000 31 Mar 2020
13F
BARD ASSOCIATES INC
13F
Company
2%
207,569
$2,640,000 31 Mar 2020
13F
Parkman Healthcare Partners LLC
13F
Company
2.4%
251,366
$1,584,000 31 Mar 2020
13F
Cowen Prime Services LLC
13F
Company
1.5%
154,800
$975,000 31 Mar 2020
13F
INGALLS & SNYDER LLC
13F
Company
1.3%
133,140
$839,000 31 Mar 2020
13F
VANGUARD GROUP INC
13F
Company
0.53%
56,737
$357,000 31 Mar 2020
13F
HighTower Advisors, LLC
13F
Company
0.41%
43,210
$273,000 31 Mar 2020
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.37%
39,863
$251,000 31 Mar 2020
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.32%
34,249
$216,000 31 Mar 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.19%
20,012
$122,000 31 Mar 2020
13F
B. Riley Wealth Advisors, Inc.
13F
Company
0.14%
14,428
$91,000 31 Mar 2020
13F
ELKHORN PARTNERS LIMITED PARTNERSHIP
13F
Company
0.12%
12,957
$82,000 31 Mar 2020
13F
BlackRock Finance, Inc.
13F
Company
0.08%
8,659
$54,000 31 Mar 2020
13F
MORGAN STANLEY
13F
Company
0.04%
3,815
$24,000 31 Mar 2020
13F
Sowell Financial Services LLC
13F
Company
0%
489
$3,000 31 Mar 2020
13F
UBS Group AG
13F
Company
0%
481
$3,000 31 Mar 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
405
$2,000 31 Mar 2020
13F
Claraphi Advisory Network, LLC
13F
Company
0%
388
$2,000 31 Mar 2020
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0%
367
$2,000 31 Mar 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
282
$2,000 31 Mar 2020
13F

Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q2 2020

As of 30 Jun 2020, NEPHROS INC - Common Stock - $0.001 par value (NEPH) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,502,818 shares. The largest 10 holders included WEXFORD CAPITAL LP, Cowen Prime Services LLC, Parkman Healthcare Partners LLC, BARD ASSOCIATES INC, OVERBROOK MANAGEMENT CORP, VANGUARD GROUP INC, HighTower Advisors, LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, BLAIR WILLIAM & CO/IL, and BlackRock Inc.. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
18
Q2 2020 holders
17
Holder diff
-1
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .